<DOC>
	<DOCNO>NCT00250146</DOCNO>
	<brief_summary>The purpose study evaluate toxicity minute dose gluten treatment celiac disease , disorder characterize permanent intolerance dietary gluten .</brief_summary>
	<brief_title>Multicenter Study Toxicity Gluten Traces Treatment Celiac Disease</brief_title>
	<detailed_description>Treatment celiac disease ( CD ) base complete avoidance gluten-containing product diet . However know whether tiny amount gluten harmful patient long-term treatment . This important issue , even strict gluten-free diet ( GFD ) usually contaminate trace gluten , e.g . wheat starch process food . The aim study investigate toxicity prolong ingestion gluten trace treat CD patient . This prospective , placebo-controlled , double-blind study . Patients adults biopsy-proven CD treatment GFD least 2 year . During study period background daily gluten intake keep low 5 mg. After baseline evaluation , patient continue GFD assign ingest 0 mg , 10 mg 50 mg daily gluten ( incorporated capsule ) 90 day . The following evaluation perform baseline micro-challenge : clinical , serological ( anti-transglutaminase antigliadin antibody ) , small intestine histology .</detailed_description>
	<mesh_term>Celiac Disease</mesh_term>
	<criteria>adult biopsyproven celiac disease glutenfree diet least 2 year apparent good health 1. patient young 18 year old ; 2. poor compliance glutenfree diet ; 3. abnormal result baseline evaluation ( positivity antitissue transglutaminase ( tTG ) antibodies and/or definitely abnormal small intestinal biopsy ; 4. associated condition , selective IgA deficiency autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>Celiac Disease</keyword>
	<keyword>Gluten</keyword>
	<keyword>Toxicity</keyword>
	<keyword>Small bowel morphometry</keyword>
</DOC>